CPC Unveils Cutting-Edge Connectors for Cell and Gene Therapy
CPC (Colder Products Company), a leading expert in connection technologies for biopharmaceutical processing, is excited to announce the launch of its groundbreaking MicroCNX® Nano Series aseptic connectors. These innovative connectors are specially designed to revolutionize sterile processing in the growing cell and gene therapy (CGT) sector.
Transforming Sterile Processing in CGT
Cell and gene therapy is advancing rapidly, yet the industry has been dependent on outdated techniques for sterile processing, such as biosafety cabinets and tube welding. Troy Ostreng, Senior Product Manager at CPC, noted, "The introduction of MicroCNX Nano connectors marks a significant leap forward. Users can effortlessly click together connector halves, establishing a sterile flow path quickly and efficiently. This innovation transforms CGT processing assemblies into streamlined systems."
Challenges in Traditional Processing Techniques
Current manufacturing processes often utilize 1/8- and 1/16-inch flow paths to transport cells with minimal turbulence and holdup volume—a challenge that arises when liquid is stuck in the tubing, making recovery difficult. Tube welding adds cumbersome extra tubing, contributing to increased holdup volume. By contrast, the MicroCNX Nano Series requires no additional tubing and allows for secure connections to be made quickly outside of biosafety cabinets.
Supporting CGT Storage and Transport
These connectors are not just efficient; they are also compact enough to fit directly into freeze cassettes used in cryopreservation for CGT products. They can withstand freezing temperatures down to -190°C, thereby protecting cell viability during both storage and transport. This feature is crucial for maintaining the integrity of sensitive biological materials.
Embracing the Future of Connected Biopharma Solutions
Troy Ostreng emphasized, "We firmly believe that small-format aseptic connectors represent the future of CGT sterile processing. MicroCNX Series connectors not only offer a swifter method for creating sterile closed systems but also enhance overall efficiency in the production process." This latest advancement is part of CPC's commitment to leading the industry with innovative solutions tailored specifically for CGT and other biopharmaceutical applications.
About CPC and Its Commitment to Innovation
CPC (Colder Products Company) stands at the forefront of single-use connection technology, providing an extensive range of connectors that cater to the complex needs of biopharmaceuticals, cell therapy, and gene therapy. The advanced solutions offered by CPC enable users to seamlessly combine components across various systems, including process containers, tubing manifolds, and bioreactors. Their well-recognized AseptiQuik® connectors facilitate quick, sterile connections, even in less-than-sterile environments, ensuring process integrity.
CPC's Broader Impact and Market Presence
As a part of Dover Corporation, which boasts an impressive annual revenue exceeding $7 billion, CPC benefits from a diversified range of resources and expertise. Dover's operational agility and commitment to innovation position both CPC and Dover as leaders in the markets they serve, providing solutions that redefine operational standards. With a workforce of approximately 24,000 employees, Dover has been fostering innovation for over 70 years, continually collaborating with clients to explore new possibilities.
Frequently Asked Questions
What is the MicroCNX Nano Series?
The MicroCNX Nano Series by CPC consists of aseptic connectors specifically designed for cell and gene therapy, enhancing sterile processing significantly.
How do these connectors improve CGT processing?
They eliminate the need for additional tubing used in traditional methods like tube welding, thus reducing holdup volume and streamlining connection processes.
What temperatures can the MicroCNX connectors withstand?
The connectors can withstand freezing temperatures as low as -190°C, making them suitable for cryopreservation applications.
Who is CPC and what do they specialize in?
CPC is a leader in single-use connection technology, focusing on connectors for biopharmaceutical applications, including cell and gene therapy.
What is Dover Corporation's role in CPC's operations?
Dover Corporation owns CPC and provides a wide array of resources and expertise, bolstering CPC’s innovative capabilities in the biopharmaceutical market.
